Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics #00447

Submission Number:
00447
Commenter:
Brad Houck
State:
Virginia
Initiative Name:
Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics
I own an independent pharmacy and see first hand how this industry works, I'm asking for you to take a bigger look and to deny the merger of CVS/Aetna. This merger would have a deleterious effect for all healthcare consumers in the US. The PBM industry already has a stranglehold on the industry and such a vertical merger would not help this problem. The PBM's derive much of their profits in the form of rebates from the pharmaceutical companies. This has, and will continue to drive up drug prices and the consumer pays the high price for this. Don't give these extortionists your blessing.